Skip to main content
. 2016 Nov 10;7(49):80164–80174. doi: 10.18632/oncotarget.13284

Figure 2. PAM identifies basal and luminal tumors in the 62 FF validation cohort.

Figure 2

A. The heatmap depicts relative expression of MDA basal (top) and luminal (bottom) markers as a function of PAM subtype assignment. B. The heatmap depicts relative expression of BASE47 basal (top) and luminal (bottom) markers as a function of PAM subtype assignment. C. Comparison of mRNA PAM subtype assignments and MDA oneNN assignments.